These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6192967)
41. [Effects of vasodilators on pulmonary hypertension]. Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964 [No Abstract] [Full Text] [Related]
42. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Rich S; Brundage BH; Levy PS Circulation; 1985 Jun; 71(6):1191-6. PubMed ID: 3995712 [TBL] [Abstract][Full Text] [Related]
43. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Daoud FS; Reeves JT; Kelly DB Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294 [No Abstract] [Full Text] [Related]
44. [Effects of vasodilators on tissue oxygenation of patients with pulmonary hypertension]. Yamamoto H; Kado T; Nakata H; Fujii H; Fukuzaki H Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Oct; 25(10):1065-71. PubMed ID: 3441074 [No Abstract] [Full Text] [Related]
45. Prostaglandins and pulmonary hypertension-further evidence. Das UN Med Hypotheses; 1981 May; 7(5):621-4. PubMed ID: 7278727 [TBL] [Abstract][Full Text] [Related]
46. Increased circulating plasma norepinephrine concentrations in noncardiac causes of pulmonary hypertension. Zaloga GP; Chernow B; Fletcher JR; Hughes P; Rainey TG; Lake CR Crit Care Med; 1984 Feb; 12(2):85-9. PubMed ID: 6697736 [TBL] [Abstract][Full Text] [Related]
47. [Effect of the preparation CIBA 31 531-Ba on respiration and pulmonary circulation]. Jedlicka K; Daum S; Nikodýmová L; Stiksa J Cas Lek Cesk; 1969 May; 108(21):629-33. PubMed ID: 5788079 [No Abstract] [Full Text] [Related]
48. The effect of certain drugs on myocardial dynamics as recorded with the high-frequency (acceleration) direct body ballistocardiograph. Winer NJ Bibl Cardiol; 1969; 26():160-73. PubMed ID: 4990120 [No Abstract] [Full Text] [Related]
49. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. Sniderman AD; Fitchett DH Int J Cardiol; 1988 Aug; 20(2):173-81. PubMed ID: 3061937 [No Abstract] [Full Text] [Related]
50. [Dynamics of electrocardiographic indices under the effect of certain hypotensive agents in patients with pulmonary hypertension]. Zaslavskaia RM; Skvortsova TP; Katseva ED Sov Med; 1970 Mar; 33(3):137-8. PubMed ID: 5419165 [No Abstract] [Full Text] [Related]
52. [Use of phentolamine in the treatment of acute pulmonary edema. Preliminary results]. Enrico JF; Poli S; Grandjean T; Perret C Schweiz Med Wochenschr; 1971 Mar; 101(9):325-8. PubMed ID: 5546277 [No Abstract] [Full Text] [Related]
53. [Nitrates in the treatment of hypoxic pulmonary hypertension]. Hamet A; Král B; Cernohorský D; Gregor J; Pospísil M; Tilser P; Eliás J; Rozánek P; Koudelka V Vnitr Lek; 1987 Apr; 33(4):332-40. PubMed ID: 3109117 [No Abstract] [Full Text] [Related]
54. Primary pulmonary hypertension; favorable effect of isoproterenol. Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096 [No Abstract] [Full Text] [Related]
55. [Therapy of primary pulmonary hypertension]. Both A Z Kreislaufforsch; 1970 Oct; 59(10):909-11. PubMed ID: 4992357 [No Abstract] [Full Text] [Related]
56. The effects of vasoactive drugs on the retinal circulation. Zahn K Trans Ophthalmol Soc U K (1962); 1966; 86():529-36. PubMed ID: 4959866 [No Abstract] [Full Text] [Related]